Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes.

被引：14
作者：
Huerta M.G. [1 ]
Nadler J.L. [1 ]
机构：
[1] 1st Floor Room #1220, Division of Endocrinology and Metabolism, University of Virginia, Fontaine Research Park, Fontaine Medical Research Building, P.O. Box 801405, 450 Ray C. Hunt Drive, Charlottesville, 22908-1405, VA
来源：
Current Diabetes Reports | 2002年 / 2卷 / 5期
关键词：
Pravastatin; Ramipril; Troglitazone; Early Atherosclerotic Lesion; Insulin Resistance Atherosclerosis Study;
D O I：
10.1007/s11892-002-0103-5
中图分类号：
学科分类号：
摘要：
Experimental and epidemiologic studies support the role of inflammation in the development of type 2 diabetes and atherosclerosis. Serum levels of inflammatory markers, in particular highly sensitive C-reactive protein, have been found to be strong predictors of increased risk for type 2 diabetes and cardiovascular disease independent of traditional risk factors. A beneficial effect of thiazolidinediones, angiotensin-converting enzyme inhibitors, and statins in the prevention of type 2 diabetes and cardiovascular events has recently been reported, and potential anti-inflammatory mechanisms of action for these compounds have been described. Prospective, randomized clinical trials are currently underway to confirm these initial findings and define indications for treatment of patients at risk.
引用
收藏
页码：396 / 402
页数：6
相关论文
共 152 条
[1]  
Ross R(1999)Atherosclerosis: an inflammatory disease N Engl J Med 340 115-126
[2]  
Stern MP(1995)Diabetes and cardiovascular disease: the "common soil" hypothesis Diabetes 44 369-374
[3]  
Pradhan AD(2001)C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus JAMA 286 327-334
[4]  
Manson JE(2000)Association between C-reactive protein and features of the metabolic syndrome Diabetes Care 23 1835-1839
[5]  
Rifai N(2001)Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am J Physiol Endocrinol Metab 280 E745-E751
[6]  
Fröhlich M(2000)Elevated levels of interleukin 6 are reduced in serum and adipose tissue of obese women after weight loss J Clin Endocrinol Metabol 85 3338-3342
[7]  
Imhof A(2000)Elevated C-reactive protein levels in overweight and obese adults JAMA 282 2131-2135
[8]  
Berg G(1999)C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction Arterioscler Thromb Vasc Biol 19 972-978
[9]  
Kern PA(2000)Chronic subclinical inflammation as part of insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 42-47
[10]  
Ranganathan S(1997)Is leptin the link between obesity and insulin resistance? Diabetes Metab 23 16-24
12345678910